Suki Kang - Search Results

Year	Number of Results
2003	2
2004	1
2005	3
2006	4
2007	2
2008	1
2010	7
2011	4
2012	3
2013	3
2014	2
2015	1
2016	6
2017	3
2018	1
2019	3
2020	3
2021	1
2023	1
2024	3

1

ITGB4-mediated metabolic reprogramming of cancer-associated fibroblasts.

Sung JS, Kang CW, Kang S, Jang Y, Chae YC, Kim BG, Cho NH. Sung JS, et al. Among authors: kang s. Oncogene. 2020 Jan;39(3):664-676. doi: 10.1038/s41388-019-1014-0. Epub 2019 Sep 18. Oncogene. 2020. PMID: 31534187

2

Nodal metastasis signatures in breast cancer.

Park K, Lee JH, Han HH, Mun SG, Kang S, Cha YJ, Koo JS, Kim MJ, Lee HS, Moon J, Cho NH. Park K, et al. Among authors: kang s. Pathol Res Pract. 2017 Jun;213(6):680-687. doi: 10.1016/j.prp.2016.11.017. Epub 2016 Dec 5. Pathol Res Pract. 2017. PMID: 28476377

3

STAT3-induced WDR1 overexpression promotes breast cancer cell migration.

Lee JH, Kim JE, Kim BG, Han HH, Kang S, Cho NH. Lee JH, et al. Among authors: kang s. Cell Signal. 2016 Nov;28(11):1753-60. doi: 10.1016/j.cellsig.2016.08.006. Epub 2016 Aug 10. Cell Signal. 2016. PMID: 27521604

4

MET overexpression in ovarian cancer via CD24-induced downregulation of miR-181a: A signalling for cellular quiescence-like state and chemoresistance in ovarian CSCs.

Kwon JE, Jang Y, Yun BS, Kang S, Kim YH, Kim BG, Cho NH. Kwon JE, et al. Among authors: kang s. Cell Prolif. 2024 May;57(5):e13582. doi: 10.1111/cpr.13582. Epub 2023 Nov 29. Cell Prolif. 2024. PMID: 38030594 Free PMC article.

5

Ovarian Clear Cell Carcinoma Sub-Typing by ARID1A Expression.

Choi JY, Han HH, Kim YT, Lee JH, Kim BG, Kang S, Cho NH. Choi JY, et al. Among authors: kang s. Yonsei Med J. 2017 Jan;58(1):59-66. doi: 10.3349/ymj.2017.58.1.59. Yonsei Med J. 2017. PMID: 27873496 Free PMC article.

6

Artificial Intelligence Techniques for Prostate Cancer Detection through Dual-Channel Tissue Feature Engineering.

Kim CH, Bhattacharjee S, Prakash D, Kang S, Cho NH, Kim HC, Choi HK. Kim CH, et al. Among authors: kang s. Cancers (Basel). 2021 Mar 26;13(7):1524. doi: 10.3390/cancers13071524. Cancers (Basel). 2021. PMID: 33810251 Free PMC article.

7

Comparative proteomics of ovarian epithelial tumors.

An HJ, Kim DS, Park YK, Kim SK, Choi YP, Kang S, Ding B, Cho NH. An HJ, et al. Among authors: kang s. J Proteome Res. 2006 May;5(5):1082-90. doi: 10.1021/pr050461p. J Proteome Res. 2006. PMID: 16674097

8

The stromal loss of miR-4516 promotes the FOSL1-dependent proliferation and malignancy of triple negative breast cancer.

Kim JE, Kim BG, Jang Y, Kang S, Lee JH, Cho NH. Kim JE, et al. Among authors: kang s. Cancer Lett. 2020 Jan 28;469:256-265. doi: 10.1016/j.canlet.2019.10.039. Epub 2019 Oct 28. Cancer Lett. 2020. PMID: 31672492

9

Mechanical compression induces VEGFA overexpression in breast cancer via DNMT3A-dependent miR-9 downregulation.

Kim BG, Gao MQ, Kang S, Choi YP, Lee JH, Kim JE, Han HH, Mun SG, Cho NH. Kim BG, et al. Among authors: kang s. Cell Death Dis. 2017 Mar 2;8(3):e2646. doi: 10.1038/cddis.2017.73. Cell Death Dis. 2017. PMID: 28252641 Free PMC article.

10

Panel of candidate biomarkers for renal cell carcinoma.

Kim DS, Choi YP, Kang S, Gao MQ, Kim B, Park HR, Choi YD, Lim JB, Na HJ, Kim HK, Nam YP, Moon MH, Yun HR, Lee DH, Park WM, Cho NH. Kim DS, et al. Among authors: kang s. J Proteome Res. 2010 Jul 2;9(7):3710-9. doi: 10.1021/pr100236r. J Proteome Res. 2010. PMID: 20455597

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

47 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year